A

Aquestive Therapeutics
D

AQST

3.01500
USD
-0.05
(-1.63%)
مغلق
حجم التداول
31,650
الربح لكل سهم
-1
العائد الربحي
-
P/E
-7
حجم السوق
274,902,252
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    B
    BHC
    0.13500
    (1.88%)
    7.31000 USD
    B
    BMRN
    -0.525
    (-0.76%)
    68.215 USD
    L
    LQDT
    -1.205
    (-3.39%)
    34.320 USD
    L
    LXRX
    -0.01440
    (-1.98%)
    0.71330 USD
    O
    OMER
    -0.41800
    (-4.35%)
    9.18500 USD
    S
    SUPN
    -1.530
    (-4.42%)
    33.060 USD
    V
    VKTX
    2.480
    (7.85%)
    34.090 USD
    المزيد
الأخبار
المقالات

العنوان: Aquestive Therapeutics

القطاع: Healthcare
الصناعة: Drug Manufacturers - Specialty & Generic
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Sympazan Oral Film, Suboxone Sublingual Film, Exservan Oral Film, and Zuplenz. The product pipeline includes Libervant Buccal Film, AQST-108, and AQST-305. The majority of its revenue comes from the United States.